Expertise in
8
conditions

Lothar Seefried

Wuerzburg, BY, DE 
Expertise in
8
conditions
Wuerzburg, BY, DE 

Overview

Lothar Seefried practices practicing medicine in Wuerzburg, Germany.

Mr. Seefried is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hypophosphatasia (HPP), Rickets, Hypophosphatemia, X-Linked Hypophosphatemia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 88 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Identification of Longitudinal Burden of Disease and Functional Impairment in X-Linked Hypophosphatemia
Identification of Longitudinal Burden of Disease and Functional Impairment in X-Linked Hypophosphatemia
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Other
A Prospective, Bi-centric,Randomized, Primary Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
A Prospective, Bi-centric,Randomized, Primary Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
Enrollment Status: Completed
Publish Date: August 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
An Investigator-sponsored Phase 3b Open-label Study of Anti- FGF23 Antibody Burosumab (KRN23) in Adult Patients With Xlinked Hypophosphatemia (XLH) in GERmany - BurGER
An Investigator-sponsored Phase 3b Open-label Study of Anti- FGF23 Antibody Burosumab (KRN23) in Adult Patients With Xlinked Hypophosphatemia (XLH) in GERmany - BurGER
Enrollment Status: Completed
Publish Date: May 03, 2023
Intervention Type: Drug
Study Drug: Burosumab
Study Phase: Phase 3
Exploratory Evaluation of the Potential for Long-term Retention of Gadolinium in the Bones of Patients Who Have Received Gadolinium Based Contrast Agents According to Their Medical History
Exploratory Evaluation of the Potential for Long-term Retention of Gadolinium in the Bones of Patients Who Have Received Gadolinium Based Contrast Agents According to Their Medical History
Enrollment Status: Completed
Publish Date: September 28, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) Observational Study
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) Observational Study
Enrollment Status: Completed
Publish Date: December 29, 2021
View 4 Less Clinical Trials

88 Total Publications

Ossification of the Posterior Longitudinal Ligament - Novel findings from Pandora's box of ENPP1 Deficiency.
Ossification of the Posterior Longitudinal Ligament - Novel findings from Pandora's box of ENPP1 Deficiency.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 07, 2026

Frequently Asked Questions about Lothar Seefried

Is Lothar Seefried a top-rated expert for Hypophosphatasia (HPP)?

MediFind is an objective health platform that identifies experts based on real-world data. Lothar Seefried is classified as an Elite expert for Hypophosphatasia (HPP), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lothar Seefried participate in research or clinical trials?

Yes. Lothar Seefried has published 88 articles and abstracts on conditions like Hypophosphatasia (HPP). You can view a list of Lothar Seefried's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Seefried's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile